Primary |
Metastases To Bone |
29.2% |
Multiple Myeloma |
15.7% |
Breast Cancer |
11.9% |
Prostate Cancer |
7.5% |
Breast Cancer Metastatic |
7.2% |
Prostate Cancer Metastatic |
5.4% |
Pain |
4.3% |
Osteoporosis |
3.7% |
Hypertension |
3.0% |
Neoplasm Malignant |
2.0% |
Depression |
1.3% |
Prophylaxis |
1.3% |
Hypercalcaemia |
1.2% |
Lung Neoplasm Malignant |
1.0% |
Bone Disorder |
1.0% |
Diabetes Mellitus |
1.0% |
Hypercalcaemia Of Malignancy |
0.9% |
Renal Cell Carcinoma |
0.8% |
Plasma Cell Myeloma |
0.8% |
Metastatic Renal Cell Carcinoma |
0.8% |
|
Osteonecrosis |
21.9% |
Tooth Extraction |
13.2% |
Death |
12.4% |
Osteonecrosis Of Jaw |
12.3% |
Pain |
5.7% |
Weight Decreased |
4.7% |
Toothache |
4.1% |
Pain In Jaw |
3.0% |
Vomiting |
2.9% |
White Blood Cell Count Decreased |
2.4% |
Osteomyelitis |
2.2% |
Terminal State |
2.1% |
Neoplasm Malignant |
1.9% |
Swelling |
1.8% |
Tooth Loss |
1.8% |
Pyrexia |
1.7% |
Wound Debridement |
1.6% |
General Physical Health Deterioration |
1.5% |
Tooth Disorder |
1.5% |
Surgery |
1.3% |
|
Secondary |
Metastases To Bone |
19.2% |
Multiple Myeloma |
15.5% |
Breast Cancer |
13.1% |
Prostate Cancer Metastatic |
8.2% |
Breast Cancer Metastatic |
7.4% |
Osteoporosis |
5.8% |
Pain |
4.8% |
Prostate Cancer |
4.0% |
Product Used For Unknown Indication |
3.7% |
Hypertension |
3.0% |
Depression |
2.8% |
Prophylaxis |
2.4% |
Drug Use For Unknown Indication |
1.9% |
Neoplasm Malignant |
1.7% |
Hypercalcaemia |
1.5% |
Plasma Cell Myeloma |
1.1% |
Bone Loss |
1.1% |
Bone Disorder |
1.0% |
Anaemia |
0.9% |
Anxiety |
0.9% |
|
Tooth Extraction |
11.6% |
Weight Decreased |
10.7% |
Death |
9.8% |
Osteonecrosis |
9.0% |
Terminal State |
8.5% |
Pain |
7.7% |
Osteonecrosis Of Jaw |
6.3% |
Vomiting |
6.0% |
Toothache |
4.4% |
General Physical Health Deterioration |
3.8% |
Neoplasm Malignant |
2.8% |
Wound Drainage |
2.5% |
Wound Debridement |
2.4% |
X-ray Abnormal |
2.2% |
Wound Dehiscence |
2.1% |
Pain In Jaw |
2.1% |
Fatigue |
2.1% |
Pneumonia |
2.1% |
Weight Increased |
2.0% |
Pyrexia |
1.9% |
|
Concomitant |
Product Used For Unknown Indication |
19.7% |
Multiple Myeloma |
15.4% |
Drug Use For Unknown Indication |
13.9% |
Prophylaxis |
9.8% |
Prostate Cancer |
4.2% |
Breast Cancer |
4.0% |
Hypertension |
3.9% |
Pain |
3.9% |
Plasma Cell Myeloma |
3.6% |
Metastases To Bone |
3.4% |
Breast Cancer Metastatic |
2.9% |
Constipation |
2.2% |
Metastatic Renal Cell Carcinoma |
2.2% |
Cancer Pain |
2.1% |
Non-small Cell Lung Cancer |
1.8% |
Nausea |
1.8% |
Prostate Cancer Metastatic |
1.4% |
Renal Cell Carcinoma |
1.4% |
Diabetes Mellitus |
1.2% |
Insomnia |
1.0% |
|
White Blood Cell Count Decreased |
9.2% |
Death |
9.0% |
Vomiting |
8.7% |
Pneumonia |
7.7% |
Weight Decreased |
7.6% |
Pyrexia |
6.5% |
Thrombocytopenia |
6.4% |
Sepsis |
4.7% |
Rash |
4.3% |
Renal Failure |
4.2% |
Pain |
3.8% |
Multiple Myeloma |
3.5% |
Renal Failure Acute |
3.4% |
Stomatitis |
3.3% |
Neutropenia |
3.1% |
Diarrhoea |
3.1% |
Neuropathy Peripheral |
3.1% |
Pancytopenia |
2.9% |
Disease Progression |
2.8% |
Osteonecrosis |
2.8% |
|
Interacting |
Metastases To Bone |
12.2% |
Rectal Cancer |
12.2% |
Prostate Cancer |
10.2% |
Adenocarcinoma |
6.1% |
Breast Cancer |
6.1% |
Breast Cancer Metastatic |
6.1% |
Hypertension |
6.1% |
Bone Disorder |
4.1% |
Bone Lesion |
4.1% |
Cardiac Failure |
4.1% |
Hypercalcaemia |
4.1% |
Multiple Myeloma |
4.1% |
Nausea |
4.1% |
Renal Cell Carcinoma |
4.1% |
Autoimmune Thyroiditis |
2.0% |
Breast Cancer Female |
2.0% |
Fracture |
2.0% |
Hyperuricaemia |
2.0% |
Hypothyroidism |
2.0% |
Lung Neoplasm Malignant |
2.0% |
|
Thrombocytopenia |
14.3% |
Hepatitis Toxic |
9.5% |
Osteonecrosis Of Jaw |
9.5% |
Blood Creatinine Increased |
4.8% |
Drug Interaction |
4.8% |
Fatigue |
4.8% |
Hair Metal Test Abnormal |
4.8% |
Hepatitis |
4.8% |
Hypokalaemia |
4.8% |
Nausea |
4.8% |
Potentiating Drug Interaction |
4.8% |
Renal Failure Acute |
4.8% |
Renal Impairment |
4.8% |
Swelling |
4.8% |
Tooth Extraction |
4.8% |
Vomiting |
4.8% |
Waist Circumference Increased |
4.8% |
|